Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Goebel, EA; Vidal, A; Matias-Guiu, X; Blake Gilks C

    The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future

    VIRCHOWS ARCHIV 472 885-896. .

    [doi:10.1007/s00428-017-2279-8]

  • Capdevila, J; Mayor, R; Mancuso, FM; Iglesias, C; Caratu, G; Matos, I; Zafon, C; Hernando, J; Petit, A; Nuciforo, P; Cameselle-Teijeiro, JM; Alvarez, C; Recio, JA; Tabernero, J; Matias-Guiu, X; Vivancos, A; Seoane, J

    Early evolutionary divergence between papillary and anaplastic thyroid cancers

    ANNALS OF ONCOLOGY 29 1454-1460. .

    [doi:10.1093/annonc/mdy123]

  • Alsina-Sanchis, E; Garcia-Ibanez, Y; Figueiredo, AM; Riera-Domingo, C; Figueras, A; Matias-Guiu, X; Casanovas, O; Botella, LM; Pujana, MA; Riera-Mestre, A; Graupera, M; Viñals F

    ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY 38 1216-1229. .

    [doi:10.1161/ATVBAHA.118.310760]

  • Bosse, T; Nout, RA; McAlpine, JN; McConechy, MK; Britton, H; Hussein, YR; Gonzalez, C; Ganesan, R; Steele, JC; Harrison, BT; Oliva, E; Vidal, A; Matias-Guiu, X; Abu-Rustum, NR; Levine, DA; Gilks, CB; Soslow, RA

    Molecular Classification of Grade 3 Endometrioid Endometrial Cancers Identifies Distinct Prognostic Subgroups

    AMERICAN JOURNAL OF SURGICAL PATHOLOGY 42 561-568. .

    [doi:10.1097/PAS.0000000000001020]

  • Garrido, P; Aldaz, A; Vera, R; Calleja, MA; de Alava, E; Martin, M; Matias-Guiu, X; Palacios, J

    Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 443-447. .

    [doi:10.1007/s12094-017-1740-0]

  • Zhu, C; Farre, G; Zanga, D; Lloveras, J; Michelena, A; Ferrio, JP; Voltas, J; Slafer, G; Savin, R; Albajes, R; Eizaguirre, M; Lopez, C; Cantero-Martinez, C; Diaz-Gomez, J; Nogareda, C; Moreno, JA; Angulo, E; Estany, J; Pena, RN; Tor, M; Portero-Otin, M; Eritja, N; Arjo, G; Serrano, JCE; Matias-Guiu, X; Twyman, RM; Sandmann, G; Capell, T; Christou, P

    High-carotenoid maize: development of plant biotechnology prototypes for human and animal health and nutrition

    PHYTOCHEMISTRY REVIEWS 17 195-209. .

    [doi:10.1007/s11101-017-9506-4]

  • Cuppens, T; Moisse, M; Depreeuw, J; Annibali, D; Colas, E; Gil-Moreno, A; Huvila, J; Carpen, O; Zikan, M; Matias-Guiu, X; Moerman, P; Croce, S; Lambrechts, D; Amant, F

    Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

    INTERNATIONAL JOURNAL OF CANCER 142 1230-1243. .

    [doi:10.1002/ijc.31129]

  • Segura, Sheila E.; Bi, Rui; Kumar, Rahul; Vidal, August; Gatius, Sonia; Abu-Rustum, Nadeem; Matias-Guiu, Xavier; DeLair, Deborah; Weigelt, Britta

    Hotspot TERT Promoter Mutations in Adult-Type Granulosa Cell Tumors of the Ovary as Potential Drivers of Progression

    Modern Pathology 31 451-451. .

  • Leon, Alicia; McAlpine, Jessica N.; Nout, Remi; McConechy, Melissa K.; Ganesan, Raji; Matias-Guiu, Xavier; Oliva, Esther; Harrison, Beth T.; Soslow, Robert; Church, David; Gilks, C. Blake; Bosse, Tjalling

    Clinicopathological Characterization of Endometrial Carcinomas with More Than One Molecular Classifying Feature

    Modern Pathology 31 434-434. .

  • Segura, SE; Bi, R; Kumar, R; Vidal, A; Gatius, S; Abu-Rustum, N; Matias-Guiu, X; DeLair, D; Weigelt, B

    Hotspot TERT Promoter Mutations in Adult-Type Granulosa Cell Tumors of the Ovary as Potential Drivers of Progression

    LABORATORY INVESTIGATION 98 451-451. .

  • Oaknin, A; Guarch, R; Barretina, P; Hardisson, D; Gonzalez-Martin, A; Matias-Guiu, X; Perez-Fidalgo, A; Vieites, B; Romero, I; Palacios, J

    Recommendations for biomarker testing in epithelial ovarian cancer: a National Consensus Statement by the Spanish Society of Pathology and the Spanish Society of Medical Oncology

    CLINICAL & TRANSLATIONAL ONCOLOGY 20 274-285. .

    [doi:10.1007/s12094-017-1719-x]

  • Van Der Putten L.J.M.; Visser N.C.M.; van de Vijver, K; Santacana, M; Bronsert, P; Bulten, J; Hirschfeld, M; Colas, E; Gil-Moreno, A; Garcia, A; Mancebo, G; Alameda, F; Trovik, J; Kopperud, RK; Huvila, J; Schrauwen, S; Koskas, M; Walker, F; Weinberger, V; Minar, L; Jandakova, E; Snijders M.P.L.M.; van den Berg-van Erp, S; Matias-Guiu, X; Salvesen, HB; Werner H.M.J.; Amant, F; Massuger L.F.A.G.; Pijnenborg J.M.A.

    Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 28 514-523. .

    [doi:10.1097/IGC.0000000000001187]

Proyectos

  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU
  • Genomic approach for individualizing endometrial cancer diagnosis, prognosis and treatment